• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在心力衰竭恶化时进行冠状动脉造影:决定因素、发现和预后意义。

Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.

机构信息

INSERM, Centre d'Investigations Cliniques Plurithématique 1433, Université de Lorraine, CHRU de Nancy and F-CRIN INI-CRCT, Nancy, France.

Cardiovascular Research and Development Unit, Department of Physiology and Cardiothoracic Surgery, University of Porto, Porto, Portugal.

出版信息

Heart. 2018 Apr;104(7):606-613. doi: 10.1136/heartjnl-2017-311750. Epub 2017 Aug 10.

DOI:10.1136/heartjnl-2017-311750
PMID:28798192
Abstract

OBJECTIVES

Coronary angiography is regularly performed in patients with worsening signs and/or symptoms of heart failure (HF). However, little is known on the determinants, findings and associated clinical outcomes of coronary angiography performed in patients with worsening HF.

METHODS

The BIOSTAT-CHF (a systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure) programme enrolled 2516 patients with worsening symptoms and/or signs of HF, either hospitalised or in the outpatient setting. All patients were included in the present analysis.

RESULTS

Of the 2516 patients included, 315 (12.5%) underwent coronary angiography within the 30 days after the onset of worsening symptoms and/or signs of HF. Subjects who underwent angiography were more often observed as inpatients, had more often an overt acute coronary syndrome, had higher troponin I levels, were younger and had better renal function (all p≤0.01). Patients who underwent coronary angiography had a lower risk of the primary outcome of death and/or HF hospitalisation (adjusted HR=0.71, 95% CI 0.57 to 0.89, p=0.003) and death (adjusted HR=0.59, 95% CI 0.43 to 0.80, p=0.001). Among the patients who underwent coronary angiography, those with a coronary stenosis (39%) had a worse prognosis than those without stenosis (adjusted HR for the primary outcome=1.71, 95% CI 1.10 to 2.64, p=0.016).

CONCLUSIONS

Coronary angiography was performed in <13% of patients with symptoms and/or signs of worsening HF. These patients were remarkably different from those who did not undergo coronary angiography and had a lower risk of subsequent events. The presence of coronary stenosis on coronary angiography was associated with a worse prognosis.

摘要

目的

在出现心力衰竭(HF)症状和/或体征恶化的患者中,常进行冠状动脉造影检查。然而,对于在 HF 恶化患者中进行冠状动脉造影检查的决定因素、检查结果和相关临床结局知之甚少。

方法

BIOSTAT-CHF(一项针对慢性心力衰竭个体化治疗的系统生物学研究)计划纳入了 2516 例出现 HF 症状和/或体征恶化的住院或门诊患者。本分析纳入了所有患者。

结果

在纳入的 2516 例患者中,有 315 例(12.5%)在 HF 症状和/或体征恶化后 30 天内进行了冠状动脉造影检查。接受造影检查的患者更多地被观察为住院患者,更常出现明显的急性冠状动脉综合征,肌钙蛋白 I 水平更高,年龄更小,肾功能更好(均 P≤0.01)。接受冠状动脉造影检查的患者发生主要结局(死亡和/或 HF 住院)的风险较低(校正 HR=0.71,95%CI 0.57 至 0.89,P=0.003)和死亡(校正 HR=0.59,95%CI 0.43 至 0.80,P=0.001)的风险也较低。在接受冠状动脉造影检查的患者中,有冠状动脉狭窄(39%)的患者预后较无狭窄者差(主要结局校正 HR=1.71,95%CI 1.10 至 2.64,P=0.016)。

结论

在出现 HF 症状和/或体征恶化的患者中,仅有不到 13%的患者进行了冠状动脉造影检查。这些患者与未接受冠状动脉造影检查的患者明显不同,且随后发生事件的风险较低。冠状动脉造影检查显示冠状动脉狭窄与预后较差相关。

相似文献

1
Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.在心力衰竭恶化时进行冠状动脉造影:决定因素、发现和预后意义。
Heart. 2018 Apr;104(7):606-613. doi: 10.1136/heartjnl-2017-311750. Epub 2017 Aug 10.
2
Coronary angiography in patients with acute heart failure: from the KCHF registry.急性心力衰竭患者的冠状动脉造影:来自 KCHF 注册研究。
ESC Heart Fail. 2022 Feb;9(1):531-544. doi: 10.1002/ehf2.13716. Epub 2021 Nov 21.
3
Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study.门诊与住院环境中心力衰竭:BIOSTAT-CHF 研究结果。
Eur J Heart Fail. 2019 Jan;21(1):112-120. doi: 10.1002/ejhf.1323. Epub 2018 Oct 19.
4
Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT.心力衰竭临床试验中首次住院和门诊心力衰竭事件的预后和治疗反应:MADIT-CRT。
Eur J Heart Fail. 2014 May;16(5):560-5. doi: 10.1002/ejhf.71. Epub 2014 Feb 27.
5
Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF.心力衰竭的病因和导致心力衰竭恶化的临床因素:来自 BIOSTAT-CHF 的研究结果。
Eur J Intern Med. 2020 Jan;71:62-69. doi: 10.1016/j.ejim.2019.10.017. Epub 2019 Nov 8.
6
Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.射血分数降低的慢性心力衰竭管理过程中肾功能恶化:脑钠肽门诊定制慢性心力衰竭治疗(PROTECT)研究结果
J Card Fail. 2017 Feb;23(2):121-130. doi: 10.1016/j.cardfail.2016.07.440. Epub 2016 Jul 25.
7
Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.CA125 在心力衰竭恶化中的临床作用:BIOSTAT-CHF 研究的亚组分析。
JACC Heart Fail. 2020 May;8(5):386-397. doi: 10.1016/j.jchf.2019.12.005. Epub 2020 Mar 11.
8
In-hospital worsening heart failure in patients admitted for acute heart failure.因急性心力衰竭入院患者的院内心力衰竭恶化
Int J Cardiol. 2016 Dec 15;225:353-361. doi: 10.1016/j.ijcard.2016.10.002. Epub 2016 Oct 5.
9
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.成纤维细胞生长因子 23 与新出现和恶化心力衰竭患者的容量超负荷、治疗优化不良和预后相关的特征有关。
Int J Cardiol. 2018 Feb 15;253:84-90. doi: 10.1016/j.ijcard.2017.10.010.
10
Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial.低体温与心力衰竭恶化患者预后不良的相关性:托伐普坦治疗心力衰竭预后评价随机对照试验(EVEREST)的一个亚组研究。
Eur J Heart Fail. 2013 Dec;15(12):1382-9. doi: 10.1093/eurjhf/hft113. Epub 2013 Jul 15.

引用本文的文献

1
Left Ventricular Ejection Fraction Predicts Outcomes in Different Subgroups of Patients Undergoing Coronary Angiography.左心室射血分数可预测接受冠状动脉造影的不同亚组患者的预后。
J Clin Med. 2025 Jul 23;14(15):5219. doi: 10.3390/jcm14155219.
2
The Impact of Coronary Ischemia Assessment on Outcomes in Those With Scar-Dependent Ventricular Tachycardia.冠状动脉缺血评估对瘢痕依赖性室性心动过速患者预后的影响。
J Cardiovasc Electrophysiol. 2025 Jan;36(1):201-211. doi: 10.1111/jce.16495. Epub 2024 Nov 15.
3
Optimizing ensemble U-Net architectures for robust coronary vessel segmentation in angiographic images.
优化集成 U-Net 架构,以实现血管造影图像中冠状动脉的稳健分割。
Sci Rep. 2024 Mar 19;14(1):6640. doi: 10.1038/s41598-024-57198-5.
4
Prognostic significance of obstructive coronary artery disease in patients admitted with acute decompensated heart failure: the ARIC study community surveillance.急性失代偿性心力衰竭患者中阻塞性冠状动脉疾病的预后意义:动脉粥样硬化风险社区研究(ARIC)的社区监测
Eur J Heart Fail. 2022 Nov;24(11):2140-2149. doi: 10.1002/ejhf.2617. Epub 2022 Aug 7.
5
Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease.有和无显著冠状动脉疾病的心力衰竭患者特征和结局的时间趋势。
ESC Heart Fail. 2022 Jun;9(3):1812-1822. doi: 10.1002/ehf2.13875. Epub 2022 Mar 8.
6
Performance of Coronary Angiography in the Detection of Coronary Artery Disease in Patients with Systolic Left Ventricular Dysfunction and No Prior Ischemic Heart Disease.冠状动脉造影术在收缩性左心室功能不全且无既往缺血性心脏病患者中检测冠状动脉疾病的性能
J Clin Med. 2022 Feb 18;11(4):1097. doi: 10.3390/jcm11041097.
7
Coronary angiography in patients with acute heart failure: from the KCHF registry.急性心力衰竭患者的冠状动脉造影:来自 KCHF 注册研究。
ESC Heart Fail. 2022 Feb;9(1):531-544. doi: 10.1002/ehf2.13716. Epub 2021 Nov 21.
8
Early invasive coronary angiography and acute ischaemic heart failure outcomes.早期有创冠状动脉造影与急性缺血性心力衰竭结局。
Eur Heart J. 2021 Sep 21;42(36):3756-3766. doi: 10.1093/eurheartj/ehab423.
9
Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets.心力衰竭患者的血浆蛋白质组学方法:对疾病进展机制及潜在新治疗靶点的见解
Eur J Heart Fail. 2020 Jan;22(1):70-80. doi: 10.1002/ejhf.1608. Epub 2019 Nov 6.
10
Identifying and Managing Hibernating Myocardium: What's New and What Remains Unknown?识别与管理冬眠心肌:新进展与未知之处?
Curr Heart Fail Rep. 2018 Aug;15(4):214-223. doi: 10.1007/s11897-018-0396-6.